Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

home run ohm. Thank you so much. Pfizer will do

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154157
(Total Views: 682)
Posted On: 05/27/2022 4:40:25 AM
Posted By: MGK_2
Re: ohm20 #123830
home run ohm. Thank you so much.
Pfizer will do as well as Gilead did.

The criteria for NAFLD are 2-3 of the following: (they are very similar to the criteria for Metabolic Syndrome);
Central Obesity waist circumference > 102cm men or 88cm women, BMI > 30
Triglycerides > 150
HDL cholesterol <40 in men; <50 in women
Hypertension >140
Glucose > 100
Microalbuminuria: albumin-creatinine ratio > 30

Both Triglycerides and HDL are lipids.
By taking a drug which increases lipids, you are in fact inducing NAFLD, and you could also be inducing Metabolic Syndrome, not to mention going against the great majority of cardiologist recommendations and protocols for cholesterol management. What cardiologist would want to prescribe a medication with the potential of increasing lipids?

What do people die of in NASH? 38% die of cardiovascular diseases. 19% die of non-liver cancer. 8% die of cirrhosis complications, 1% die of Hepatocellular carcinoma; 8% die of infections. <1% die of liver transplant.
the rest is other.

Elevated lipids leads to cardiovascular disease which has significant morbidity and mortality associated with Metabolic Syndrome. Do you want to risk that to reduce liver fat? Doesn't seem logical.

Big pharma loves keeping the status quo of disease. After all, without disease, there is no Big Pharma.

Resmetirom - selective thyromimetic, which selectively improves the hypothyroid state of the liver only, is more of a competitor to LL than the ACC inhibitor / DGAT2 inhibitor combo.

Remember those small percent losses in weight leading to big improvements in NAS score? No, the drug they propose gets rid of the fat by increasing lipids. How long will that last? When you stop taking the drug, the fat comes back because it is not operating at the root of the problem. Better off eating a Mediterranean diet & doing activity, lay off the carbs, the foods which increase lipids. Not according to Big Pharma, they have you taking meds which can significantly increase lipids.

I guess they also want you to double your dose of Statins. That would be another way to induce a counter effect on the drug they propose.


(4)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us